pancreatic cancer
Repare Therapeutics Shuffles Pipeline, Pauses Some Programs Pending Partnership
The firm will pause development of lunresertib and camonsertib while focusing on development of two newer programs.
U of Southampton to Use ClearNote Health Test in Large-Scale Pancreatic Cancer Surveillance Study
The epigenetic test will look for signs of pancreatic cancer among adults newly diagnosed with type 2 diabetes in a trial that aims to enroll up to 15,000 participants.
Candel Therapeutics to Raise $80M in Public Stock and Warrants Offering
The firm plans to put the funds toward a biologics licensing application for its lead product candidate CAN-2409 in prostate cancer.
Merus Nabs FDA Accelerated Approval for Bizengri in NRG1 Fusion-Positive NSCLC, Pancreatic Cancer
The approval is based on overall response rates from the Phase II eNRGy study, which enrolled advanced, previously treated NRG1 fusion-positive patients.
Anocca Seeking EMA Permission to Test TCR T-Cell Therapy in KRAS-Mutated Pancreatic Cancer
The Swedish firm plans to expand the VIDAR-1 umbrella trial to study additional KRAS-targeting product candidates in the future.
Sep 17, 2024
Aug 27, 2024
Mar 21, 2024